Bariatric Surgery for Morbid Obesity

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2011

Study Completion Date

March 31, 2012

Conditions
ObesityMorbid Obesity
Interventions
PROCEDURE

Initial Surgery

"NO patients had initial abdominal laparoscopic surgery at study entry, during which research fat biopsies were obtained, completing their participation.~MO patients had initial laparoscopic bariatric surgery (gastric bypass, adjustable gastric band, or sleeve gastrectomy) and fat biopsies at entry, completing their participation.~All 30 SMO patients had initial laparoscopic bariatric surgery (sleeve gastrectomy) \& fat biopsies. The first 10 to lose 100 lbs but who needed further surgery to reach optimal weight and who consented to further surgery underwent a 2nd laparoscopic bariatric surgery (either a biliopancreatic diversion with duodenal switch or a Roux-en-Y gastric bypass) and biopsies. The interval between surgeries averaged 15 mos. and the weight loss 55 kg. 30 SMO patients were initially enrolled to insure that 10 would complete 2 surgeries. When 10 had had their 2nd operation, the study was considered complete, and the remaining 20 SMO participants were so notified."

PROCEDURE

Second Bariatric Surgery

A second bariatric procedure was performed on only 10 of the original 30 Super-morbidly Obese (SMO) subjects.

Trial Locations (1)

10032

Columbia University, New York

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Columbia University

OTHER

NCT00675558 - Bariatric Surgery for Morbid Obesity | Biotech Hunter | Biotech Hunter